Wen Jin Wu
Division of Monoclonal Antibodies Food and Drug Administration, USA
Dr. Wen Jin Wu obtained his MD in China in 1983 and completed his PhD at Cornell University in 2002. After finishing his PhD he continued working at Cornell University as a Research Associate He was recruited as a Principal Investigator PI in Division of Monoclonal Antibodies Office of Biotechnology Products at FDA in 2004. Since 2004 he has directed a research program focusing on understanding the roles of Rho family GTPases and ErbB receptor tyrosine kinases in breast cancer progression and investigating the mechanisms of trastuzumabresistance He has published a number of papers in reputed journals including Journal of Biological Chemistry Nature Cell and Cancer Research.
Monoclonal antibodies, Cell biology , cancer research